Pluri Inc. (PLUR) — SEC Filings
Pluri Inc. (PLUR) — 40 SEC filings. Latest: 8-K (Mar 27, 2026). Includes 30 8-K, 6 10-Q, 2 10-K.
Overview
Pluri Inc. (PLUR) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Mar 27, 2026: On March 25, 2026, Pluri Inc. entered into a Securities Purchase Agreement and a related Warrant Agreement. These agreements involve the unregistered sale of equity securities, the details of which are filed under Item 3.02 of the 8-K.
Sentiment Summary
Across 40 filings, the sentiment breakdown is: 5 bearish, 34 neutral, 1 mixed. The dominant filing sentiment for Pluri Inc. is neutral.
Filing Type Overview
Pluri Inc. (PLUR) has filed 30 8-K, 6 10-Q, 2 10-K, 1 DEF 14A, 1 SC 13G/A with the SEC between Jan 2024 to Mar 2026.
Filings by Year
Recent SEC Filings (40)
Risk Profile
Risk Assessment: Of PLUR's 37 recent filings, 6 were flagged as high-risk, 22 as medium-risk, and 9 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $316K |
| Net Income | -$6.132M |
| EPS | N/A |
| Debt-to-Equity | N/A |
| Cash Position | $16.393M |
| Operating Margin | N/A |
| Total Assets | $33.672M |
| Total Debt | $27.541M |
Industry Context
Pluri Inc. operates in the biotechnology sector, specifically focusing on cell-based technologies. This industry is characterized by high R&D costs, long development cycles, and significant regulatory hurdles. The competitive landscape includes established pharmaceutical companies and numerous startups vying for innovation and market share. Trends include advancements in regenerative medicine, personalized therapies, and sustainable food production, areas where Pluri Inc. is attempting to position itself.
Top Tags
material-agreement (7) · corporate-governance (7) · equity-sale (6) · 8-K (5) · regulatory-filing (5) · listing-standards (5) · 10-Q (5) · delisting (4) · 8-k (3) · filing (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Loss | $6.132M | Increased from $6.036M in Q3 2024 |
| Revenues | $316K | Decreased from $326K in Q3 2024 |
| Gross Profit | $115K | Decreased from $200K in Q3 2024 |
| Net Research and Development Expenses | $3.931M | Increased from $2.889M in Q3 2024 |
| Accumulated Deficit | $448.905M | As of September 30, 2025 |
| Total Shareholders' Deficit | $11.360M | As of September 30, 2025 |
| Net Cash Used for Operating Activities | $5.428M | Increased from $4.064M in Q3 2024 |
| Total Cash Balances | $16.393M | As of September 30, 2025, down from $22.095M at June 30, 2025 |
| EIB Loan Balance | $27.541M | Due June 1, 2026, and classified as short-term liability |
| Common Shares Outstanding | 9,253,897 | As of November 11, 2025 |
| Aggregate market value of common equity held by non-affiliates | $22,209,416 | as of the last business day of the most recently completed second fiscal quarter |
| Shares outstanding | 8,155,948 | as of September 16, 2025 |
| Pluri Biotech's ownership in Ever After Foods | 69% | following the $10 million private placement offering |
| Gross proceeds from Ever After Foods' private placement offering | $10 million | completed in June 2024 |
| Pluri's investment in Ever After Foods' private placement offering | $1.25 million | part of the June 2024 funding round |
Frequently Asked Questions
What are the latest SEC filings for Pluri Inc. (PLUR)?
Pluri Inc. has 40 recent SEC filings from Jan 2024 to Mar 2026, including 30 8-K, 6 10-Q, 2 10-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of PLUR filings?
Across 40 filings, the sentiment breakdown is: 5 bearish, 34 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Pluri Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Pluri Inc. (PLUR) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Pluri Inc.?
Key financial highlights from Pluri Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for PLUR?
The investment thesis for PLUR includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Pluri Inc.?
Executive information for Pluri Inc. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Pluri Inc. stock?
Of PLUR's 37 assessed filings, 6 were flagged high-risk, 22 medium-risk, and 9 low-risk.
What are recent predictions and forward guidance from Pluri Inc.?
Forward guidance and predictions for Pluri Inc. are extracted from SEC filings as they are enriched.